Akebia Therapeutics, Inc. (AKBA)

NASDAQ: AKBA · Real-Time Price · USD

3.970

+0.280 (7.59%)

At close: Jun 6, 2025, 4:00 PM

4.000

+0.030 (0.76%)

After-hours: Jun 6, 2025, 7:50 PM EDT

Revenue by Product

Fiscal year is January - December.

Fiscal Year	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	2016 - 2018
Period Ending	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	2016 - 2018
Novel Therapeutics	194.62M	Log In	Log In	Log In	Log In	Upgrade
Novel Therapeutics Growth	-33.46%	Log In	Log In	Log In	Log In	Upgrade

Revenue by Geography

Fiscal year is January - December.

Fiscal Year	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	2016 - 2018
Period Ending	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	2016 - 2018
United States	194.62M	Log In	Log In	Log In	Log In	Upgrade
United States Growth	-33.46%	Log In	Log In	Log In	Log In	Upgrade